(Q64173331)

English

Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Multicenter, Double-Blind Study of the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy Pneumococcal Vaccine-Naïve Adults 50 Years of Age or Older (English)

0 references

start time

8 October 2015

0 references

end time

20 January 2016

0 references

number of participants

690

0 references

clinical trial phase

phase II clinical trial

0 references

minimum age

50 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT02547649

0 references

(Q64173331)

Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)